Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Ikeda

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Science|February 7, 2017
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Internal Medicine (Tokyo, Japan)|September 18, 2025
Clinical Practice of Treatment Switch in Transplant-eligible Patients with Multiple Myeloma: An Exploratory Retrospective AnalysisSho Ikeda, Takahiro Kobayashi, Akihiro Kitadate, et al.
Blood Advances|August 5, 2022
EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stressJiro Kikuchi, Nobuyuki Kodama, Masataka Takeshita, et al.
Case Reports in Hematology|April 25, 2020
CD7-Positive Diffuse Large B-Cell Lymphoma Presenting as an Intranasal TumorKazuaki Teshima, Masaaki Kume, Yasushi Kawaharada, et al.
International Journal of Clinical Oncology|October 19, 2012
Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropeniaShinsuke Noguchi, Naoto Takahashi, Mitsugu Ito, et al.
Blood Neoplasia|September 15, 2025
Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14)<sup></sup>Sae Matsuoka, Naoki Osada, Hirokazu Kubota, et al.
Future Oncology (London, England)|February 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)Yu Abe, Shiro Kubonishi, Masaki Ri, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Science|February 7, 2017
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Internal Medicine (Tokyo, Japan)|September 18, 2025
Clinical Practice of Treatment Switch in Transplant-eligible Patients with Multiple Myeloma: An Exploratory Retrospective AnalysisSho Ikeda, Takahiro Kobayashi, Akihiro Kitadate, et al.
Blood Advances|August 5, 2022
EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stressJiro Kikuchi, Nobuyuki Kodama, Masataka Takeshita, et al.
Case Reports in Hematology|April 25, 2020
CD7-Positive Diffuse Large B-Cell Lymphoma Presenting as an Intranasal TumorKazuaki Teshima, Masaaki Kume, Yasushi Kawaharada, et al.
International Journal of Clinical Oncology|October 19, 2012
Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropeniaShinsuke Noguchi, Naoto Takahashi, Mitsugu Ito, et al.
Blood Neoplasia|September 15, 2025
Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14)<sup></sup>Sae Matsuoka, Naoki Osada, Hirokazu Kubota, et al.
Future Oncology (London, England)|February 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)Yu Abe, Shiro Kubonishi, Masaki Ri, et al.
Pageof 4